|Place of Origin:||China|
|Model Number:||Granules, 0.125g|
|Minimum Order Quantity:||5000 boxes|
|Packaging Details:||50 bags/box|
|Delivery Time:||45 days|
|Supply Ability:||10, 000 boxes per day|
|Product:||Amoxicillin Granules||Specification:||Granules, 0.125g|
|Granules, 0.125g:||BP,USP,EP||Packing:||10 X 10/box|
Amoxicillin Antibiotics Granules 0.125g Antibiotic Drugs For Infection Treatment
Product : Amoxicillin Granules
Specification : Granules, 0.125g
Standard : BP,USP,EP
Packing : 50 bags/box
For the treatment of infections of the ear, nose, and throat, the genitourinary tract, the skin and skin structure, and the lower respiratory tract due to susceptible (only b-lactamase-negative) strains of Streptococcus spp. (a- and b-hemolytic strains only), S. pneumoniae, Staphylococcus spp., H. influenzae, E. coli, P. mirabilis, or E. faecalis. Also for the treatment of acute, uncomplicated gonorrhea (ano-genital and urethral infections) due to N. gonorrhoeae (males and females).
Amoxicillin is a moderate-spectrum antibiotic active against a wide range of Gram-positive, and a limited range of Gram-negative organisms. It is usually the drug of choice within the class because it is better absorbed, following oral administration, than other beta-lactam antibiotics. Amoxicillin is susceptible to degradation by β-lactamase-producing bacteria, and so may be given with clavulanic acid to increase its susceptability. The incidence of β-lactamase-producing resistant organisms, including E. coli, appears to be increasing. Amoxicillin is sometimes combined with clavulanic acid, a β-lactamase inhibitor, to increase the spectrum of action against Gram-negative organisms, and to overcome bacterial antibiotic resistance mediated through β-lactamase production.